Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 22 December. Jeff Hawkins.

Executive Summary

The pandemic has ushered in a new era in point-of-care testing in which technologies are increasingly becoming more accessible, more affordable and more convenient, according to a panel discussion at the recent virtual AACC 2020 conference. See what panelist Jeff Hawkins, CEO of Truvian Sciences, said about it here.

“There is something really interesting not just from a clinical outcomes perspective, but also from a health economics perspective and consumer preferences that are going to start making the landscape be very different for point-of-care companies as we introduce [tests] to the market.” – Jeff Hawkins, CEO, Truvian Sciences

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts